Parkinson's - Michael J. Fox Foundation Alpha-synuclein Pathology LEAPS 2014 ($ 750,000)

The Michael J. Fox Foundation (MJFF) asks for applications for its Alpha-synuclein Pathology LEAPS 2014. The closing date to submit pre-proposals is June 16, 2014. The goal of this programme is to promote collaborative analyses of human samples for identification of Alpha-synuclein (aSyn) species in Parkinson's disease. MJFF intends to support multiple awards through this funding program.

Applicants may request up to US $ 750,000 total costs (inclusive of both direct and indirect costs) to support up to a two-year research plan. Funding will utilize MJFF's 'LEAPS' (Linked Efforts to Accelerate Parkinson's Solutions) model to support 'all-star', multi-institutional teams to develop and execute systematic, milestone-driven plans for addressing clearly defined challenges in the aSyn biology field.

Please note that the Foundation also has an upcoming deadline of May 28, 2014 for its Target Validation Program and its Therapeutic Pipeline Program. In general, the Foundation emphasizes funding translational and clinical research. It also supports high-risk/high-reward discovery work to help keep new ideas flowing into the drug development pipeline.